SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.04.05 | Novartis Hold | SEB | |
| 27.04.05 | Novartis Kaufen | NATIONAL-BANK | |
| 21.04.05 | Roche Outperform | Goldman Sachs | |
| 22.04.05 | Novartis Kaufen | Helaba Trust | |
| 21.04.05 | Roche Sector Outperform | Vontobel | |
| 21.04.05 | Novartis Buy | Merrill Lynch | |
| 21.04.05 | Novartis Akkumulieren | Independent Research | |
| 21.04.05 | Novartis Neutral | Sarasin Research | |
| 20.04.05 | Roche Buy | Sarasin Research | |
| 20.04.05 | Roche Equal weight | Lehman Brothers | |
| 20.04.05 | Roche Outperform | Goldman Sachs | |
| 20.04.05 | Roche Overweight | JP Morgan | |
| 19.04.05 | Novartis Buy | Merrill Lynch | |
| 19.04.05 | Roche Halten | Helaba Trust | |
| 21.04.05 | Novartis Underperform | Credit Suisse First Boston | |
| 19.04.05 | Roche Buy | Sarasin Research | |
| 19.04.05 | Roche Akkumulieren | Independent Research | |
| 19.04.05 | Novartis Neutral | JP Morgan | |
| 19.04.05 | Roche Overweight | JP Morgan | |
| 18.04.05 | Novartis Outperform | Goldman Sachs | |
| 19.04.05 | Roche Equal weight | Lehman Brothers | |
| 18.04.05 | Novartis Neutral | HypoVereinsbank | |
| 15.04.05 | Roche In-Line | Goldman Sachs | |
| 15.04.05 | Novartis Kaufen | Helaba Trust | |
| 18.04.05 | Roche Buy | Helvea | |
| 18.04.05 | Novartis Neutral | Sarasin Research | |
| 15.04.05 | Roche In-Line | Goldman Sachs | |
| 18.04.05 | Roche Outperform | HypoVereinsbank | |
| 18.04.05 | Roche Buy | Sarasin Research | |
| 14.04.05 | Novartis Reduce | UBS | |
| 14.04.05 | Novartis Reduce | UBS | |
| 14.04.05 | Roche Halten | Helaba Trust | |
| 15.04.05 | Novartis Underperform | Credit Suisse First Boston | |
| 15.04.05 | Roche Buy | SES Research | |
| 13.04.05 | Lonza Reduce | Sarasin Research | |
| 13.04.05 | Novartis Neutral | Sarasin Research | |
| 11.04.05 | Lonza Overweight | JP Morgan | |
| 08.04.05 | Novartis Accumulate | Helvea | |
| 07.04.05 | Lonza Reduce | Sarasin Research | |
| 06.04.05 | Roche Buy | Helvea |